PACSHealth Showcases DoseMonitor Upgrade at Chicago Trade Show
|
By MedImaging International staff writers Posted on 27 Nov 2017 |

Image: The latest version of DoseMonitor is being shown by PACSHealth at RSNA 2017 (Photo courtesy of PACSHealth).
PACSHealth, LLC (Scottsdale, Arizona, USA), a developer of medical imaging informatics software, showcased the upgraded DoseMonitor version 2.5.2, at the annual meeting of RSNA (Radiological Society of North America), held from November 26th through November 30th in Chicago, Illinois.
DoseMonitor is an automated, enterprise-wide, vendor neutral patient radiation dose data collection, aggregation and reporting system. It identifies patients who may be at risk for ionizing radiation overexposure based on customer-provided thresholds and guidelines. By managing radiation dose effectively, facilities can adapt to new technologies and meet evolving regulatory standards and operations compliance requirements.
The latest version adds improved analytics, new interactive reporting graphics, post-procedure Peak Skin Dose (PSD) calculations and visualization for interventional radiology, CT/MR contrast data management, and exclusive support for non-ionizing modalities such as MRI.
In addition to these new features, DoseMonitor continues to lead in pre-exam organ dose modeling tools using both NCICT Phantoms and Virtual Phantoms. In 2016, DoseMonitor was the first to incorporate the National Institutes of Health (NIH) National Cancer Institute (NCI) dosimetry system for computed tomography (NCICT).
"We have incorporated these industry leading features into DoseMonitor to assist customers with regulatory compliance while providing accurate and efficient diagnostic imaging procedures," said Mike Battin, COO of PACSHealth.
DoseMonitor is an automated, enterprise-wide, vendor neutral patient radiation dose data collection, aggregation and reporting system. It identifies patients who may be at risk for ionizing radiation overexposure based on customer-provided thresholds and guidelines. By managing radiation dose effectively, facilities can adapt to new technologies and meet evolving regulatory standards and operations compliance requirements.
The latest version adds improved analytics, new interactive reporting graphics, post-procedure Peak Skin Dose (PSD) calculations and visualization for interventional radiology, CT/MR contrast data management, and exclusive support for non-ionizing modalities such as MRI.
In addition to these new features, DoseMonitor continues to lead in pre-exam organ dose modeling tools using both NCICT Phantoms and Virtual Phantoms. In 2016, DoseMonitor was the first to incorporate the National Institutes of Health (NIH) National Cancer Institute (NCI) dosimetry system for computed tomography (NCICT).
"We have incorporated these industry leading features into DoseMonitor to assist customers with regulatory compliance while providing accurate and efficient diagnostic imaging procedures," said Mike Battin, COO of PACSHealth.
Latest RSNA 2017 News
- Siemens Healthineers Launches New Mammography System at RSNA
- New Real-Time Imaging AI Platform Unveiled
- Bracco Diagnostics Highlights Advancement in Diagnostic Imaging Portfolio
- Varex Imaging Showcases New X-ray Components at Trade Fair
- Samsung Unveils New Mobile CT at RSNA 2017
- Thales Unveils World’s First Portable Detector with Embedded Patient ID
- Carestream Exhibits New Diagnostic Imaging Solutions in Chicago
- Siemens Healthineers Spotlights Advances in Breast Imaging
- Agfa HealthCare Presents Advances in AI and Machine Learning at RSNA 2017
- Philips Showcases New Imaging Systems and Informatics Portfolio at RSNA
- Fujifilm Debuts New FDR Go PLUS Version Portable System
- Canon Showcases New DR Systems at Medical Imaging Fair
- Aspect Imaging Presents Neonatal MRI System at RSNA 2017
- Visage Imaging Debuts AI Offerings at Chicago Show
- Carestream Joins Zebra Medical Vision to Provide Access to AI Algorithms
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read more
Advanced MRI System Detects Impaired Cardiac Oxygen Use in Minutes
Early identification of cardiac dysfunction remains challenging because current methods to evaluate myocardial oxygen use are invasive or impractical for routine care. Delays in detecting impaired oxygen... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more








